drugset / Trial / NCT02159313

Relative Bioavailability Study

NCT02159313

Phase 1 Completed 48 enrolled Bayer
RandomizedCrossoverOpen-label

Summary

To investigate relative bioavailability of crushed tablets suspended in apple sauce or water

Timeline

Start
2014-06
Primary completion
2014-09
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Riociguat Other / unclassified 2.5 mg Oral

Indications

No indication recorded.